Equities
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)1.03
  • Today's Change0.10 / 10.75%
  • Shares traded1.11m
  • 1 Year change-63.08%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,6612,9973,355
Total Receivables, Net715852
Total Inventory------
Prepaid expenses48207.37
Other current assets, total3.342.200.32
Total current assets2,7833,0773,414
Property, plant & equipment, net5.612033
Goodwill, net------
Intangibles, net2671479.51
Long term investments142146152
Note receivable - long term------
Other long term assets02.512.79
Total assets3,1983,3923,612
LIABILITIES
Accounts payable------
Accrued expenses4848173
Notes payable/short-term debt000
Current portion long-term debt/capital leases3.169.508.97
Other current liabilities, total7517199
Total current liabilities126229281
Total long term debt03.1613
Total debt3.161322
Deferred income tax------
Minority interest(47)(37)(32)
Other liabilities, total02.087.08
Total liabilities79197269
SHAREHOLDERS EQUITY
Common stock0.020.020.02
Additional paid-in capital9,3779,3529,317
Retained earnings (accumulated deficit)(6572)(6447)(6013)
Treasury stock - common(0.07)----
Unrealized gain (loss)(37)(18)12
Other equity, total35230826
Total equity3,1193,1953,343
Total liabilities & shareholders' equity3,1983,3923,612
Total common shares outstanding729727720
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.